Post-earnings recap
Reported
Thu, Jan 26, 2012
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
Amgen's earnings report showed a slight beat on EPS, but the stock reacted negatively, dropping 1.6%. The lack of revenue data and forward guidance may have contributed to investor caution. Overall, the company appears stable but lacks clear direction for future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.21 | N/A | +1.26% |
| Revenue | N/A | N/A | N/A |
Management expressed a steady outlook without offering detailed future projections. They emphasized the importance of their existing product lineup.
Management did not provide specific guidance for future quarters.
The company remains focused on its core products and pipeline.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—